New Directions in the Uses of Retinoid Therapy in Cosmetic Dermatology

A supplement to Skin & Allergy News supported by an unrestricted educational grant from OrthoNeutrogena.
Highlights of articles based on clinical dialogues with the faculty.

•Contents
•Target Audience
•Educational Needs
•Learning Objectives
•Accreditation

To view the supplement, click the image above. To take the CME test, download and print out the PDF file, and follow the test instructions on page 11.

Contents

Photodamage: An Overview
James J. Leyden, MD
Professor Emeritus, Department of Dermatology
University of Pennsylvania School of Medicine
Philadelphia
Clinical Grant: OrthoNeutrogena; Consultant: Allergan.

Topical Treatments for Photodamage
Leslie S. Baumann, MD
Director, Division of Cosmetic Dermatology
Department of Dermatology
University of Miami
Clinical Grants: Galderma, Allergan, and Elan. She discusses the investigational use of retinoids and botulinum toxin for the prevention of aging.

Rejuvenation: Skin Resurfacing
Tina S. Alster, MD
Director, Washington Institute of Dermatologic Laser Surgery
Clinical Assistant Professor of Dermatology and Pediatrics
Georgetown University Medical Center
Washington, DC
Nothing to disclose.

Target Audience

This activity has been developed for dermatologists and other health care professionals involved in the diagnosis, treatment, and long-term management of patients with photodamaged skin.

Educational Needs

Concerns over the visible signs of aging is one of the more common reasons that patients consult dermatologists. Although some of the manifestations of aging are intrinsic and cannot be reversed, prematurely aged skin as a result of photodamage can be treated with myriad techniques that reduce and/or prevent clinical signs such as wrinkles, mottled pigmentation, sallow color, and coarse texture. Dermatologists need to keep abreast of the most current research findings regarding topical therapies, including retinoid agents, topical antioxidants, and alpha hydroxy acid products. They also need to be aware of advancements made in resurfacing technology, especially new-generation laser therapy and chemical peel processes.

Learning Objectives

By reading and studying this supplement, participants should be able to:

• Summarize the histologic changes that occur in photodamaged skin.

• Describe how both UVA and UVB light contribute to photodamage.

• List at least three retinoid agents and three nonretinoid agents used as topical treatments for photodamaged skin.

• Describe the most common side effects associated with retinoid agents and regiments that may be used to help patients minimize them.

• Identify the ideal candidates for superficial, medium, and deep chemical peels.

• Explain how the various laser technologies differ from one another.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Excerpta Medica, Inc., and Skin & Allergy News. Excerpta Medica is accredited by the ACCME to provide continuing medical education for physicians.

Excerpta Medica designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity. Term of Approval: July 2003-July 2004.

Copyright © 2003 by International Medical News Group

---